Home

shromáždění Drahý oběh double expresor vs double hit overall survival moje maličkost Opice Rychlost

Double hit and double expressors in lymphoma: Definition and treatment -  Riedell - 2018 - Cancer - Wiley Online Library
Double hit and double expressors in lymphoma: Definition and treatment - Riedell - 2018 - Cancer - Wiley Online Library

Exploiting the Molecular Heterogeneity of Aggressive B-Cell Lymphomas to  Develop Effective New Therapies
Exploiting the Molecular Heterogeneity of Aggressive B-Cell Lymphomas to Develop Effective New Therapies

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have  Inferior Progression-Free Survival After Autologous Stem-Cell  Transplantation. | Semantic Scholar
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. | Semantic Scholar

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or  BCL6 rearrangements is not associated with MYC/IG gene rearrangements |  Haematologica
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica

Prognostic impact of diffuse large B-cell lymphoma with extra copies of  MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and  double expressor lymphoma | Diagnostic Pathology | Full Text
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text

MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison  to MYC/BCL2 and MYC/BCL6 double hit lymphomas | Modern Pathology
MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas | Modern Pathology

Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes:  Discrete Subtypes and Major Predictors of Overall Survival | SpringerLink
Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | SpringerLink

Double hit lymphoma: How do we define it and how do we treat it? -  ScienceDirect
Double hit lymphoma: How do we define it and how do we treat it? - ScienceDirect

MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison  to MYC/BCL2 and MYC/BCL6 double hit lymphomas | Modern Pathology
MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas | Modern Pathology

How I treat double-hit lymphoma - ScienceDirect
How I treat double-hit lymphoma - ScienceDirect

Kaplan-Meier curves of progression-free survival and overall survival.... |  Download Scientific Diagram
Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram

Diffuse Large B Cell Lymphoma:
Diffuse Large B Cell Lymphoma:

Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes:  Discrete Subtypes and Major Predictors of Overall Survival | SpringerLink
Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | SpringerLink

Double hit and double expressors in lymphoma: Definition and treatment -  Riedell - 2018 - Cancer - Wiley Online Library
Double hit and double expressors in lymphoma: Definition and treatment - Riedell - 2018 - Cancer - Wiley Online Library

Increased MYC copy number is an independent prognostic factor in patients  with diffuse large B-cell lymphoma | Modern Pathology
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma | Modern Pathology

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or  BCL6 rearrangements is not associated with MYC/IG gene rearrangements |  Haematologica
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica

PFS (A) and OS (B) of patients divided into two groups according to MYC...  | Download Scientific Diagram
PFS (A) and OS (B) of patients divided into two groups according to MYC... | Download Scientific Diagram

Diagnostics | Free Full-Text | Molecular Diagnostic Review of Diffuse Large  B-Cell Lymphoma and Its Tumor Microenvironment
Diagnostics | Free Full-Text | Molecular Diagnostic Review of Diffuse Large B-Cell Lymphoma and Its Tumor Microenvironment

Frontiers | Enhanced lipid metabolism confers the immunosuppressive tumor  microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma
Frontiers | Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma

Patterns of Failure in Patients With Double Hit or Double Expressor  Lymphomas: Implications for Radiation Therapy - ScienceDirect
Patterns of Failure in Patients With Double Hit or Double Expressor Lymphomas: Implications for Radiation Therapy - ScienceDirect

How should we treat double hit and double expressor lymphomas?
How should we treat double hit and double expressor lymphomas?

Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit  and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation

How should we treat double hit and double expressor lymphomas?
How should we treat double hit and double expressor lymphomas?

Diffuse Large B Cell Lymphoma:
Diffuse Large B Cell Lymphoma:

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have  Inferior Progression-Free Survival After Autologous Stem-Cell  Transplantation. | Semantic Scholar
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. | Semantic Scholar

PFS (A) and OS (B) comparing R-DA-EPOCH and R-CHOP regimen in 26 cases... |  Download Scientific Diagram
PFS (A) and OS (B) comparing R-DA-EPOCH and R-CHOP regimen in 26 cases... | Download Scientific Diagram

Prognostic impact of diffuse large B-cell lymphoma with extra copies of  MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and  double expressor lymphoma | Diagnostic Pathology | Full Text
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text

Cancers | Free Full-Text | The Incidence and Treatment Response of Double  Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma:  A Systematic Review and Meta-Analysis
Cancers | Free Full-Text | The Incidence and Treatment Response of Double Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young  patients affected by double expressor diffuse large B-cell lymphoma |  Leukemia
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia